HYBRID EVENT: You can participate in person at Boston, Massachusetts, USA or Virtually from your home or work.
Philippe P Pagni, Speaker at Diabetes Conferences
Philippe P Pagni
Novo Nordisk Research Center, United States


Phil Pagni holds a PhD in Immunology from Aix-Marseille University obtained at the Center of Immunology of Marseille-Luminy. He pursued his postdoctoral training at the La Jolla Institute for Immunology (LJI) in Prof. Matthias von Herrath’s lab, evaluating immune-mediated combination therapies to prevent or reverse the course of type 1 diabetes in mouse models.

At Novo Nordisk since 2013, Phil is a scientist experienced in immunology and autoimmunity including type 1 diabetes. As Head of the Immunobiology department in Lexington, Phil’s mission is to provide safe, immune-mediated targets across various cardiometabolic and rare diseases within Novo Nordisk’s pipeline.